Brief: Ocean Biomedical Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
16/05/2024 13:09
May 16 (Reuters) - Ocean Biomedical Inc OCEA.O :
* OCEAN BIOMEDICAL, INC. (NASDAQ: OCEA) ANNOUNCES PATENT
ALLOWANCE
FOR MALARIA ANTIBODIES THAT HAVE POTENTIAL CAPABILITY TO PROTECT
AGAINST INFECTION AND TREAT SEVERE DISEASE
Source text for Eikon: ID:nGNX3LgHyY
Further company coverage: OCEA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocean Biomedical
See all newsTrump's shipbuilding plan could upend ocean cargo industry, companies warn
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26